Investing.com — oil stocks likely plunged by more than 15 million barrels last week, with deficits in inventories of gasoline and distillates too, amid...
Introduction TG Therapeutics, Inc. (NASDAQ:TGTX) develops and markets treatments for B-cell malignancies and autoimmune diseases. Their FDA-approved product, Briumvi, is a monoclonal antibody therapy...